{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-036057","form_type":"8-K","ticker":"MIRA","cik":"0001904286","company_name":"MIRA PHARMACEUTICALS, INC.","filed_at":"2024-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.169530+00:00","generated_at":"2026-05-31T05:18:42.704493+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"MIRA Pharmaceuticals announces 2024 annual meeting results; all proposals approved","bullets":["All five director nominees elected; each received over 6.6M votes (70.4% of votes cast).","Ratification of Cherry Bekaert LLP as auditor for FY2024 approved with 9.4M votes for (99.9%).","Amendment to 2022 Omnibus Incentive Plan to increase available shares approved with 6.57M votes for (84.6% of votes cast).","Adjournment proposal withdrawn after sufficient votes obtained for proposals 1 and 3."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-036057","json":"https://secwatch.observer/filing/0001493152-24-036057.json","markdown":"https://secwatch.observer/filing/0001493152-24-036057.md","text":"https://secwatch.observer/filing/0001493152-24-036057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224036057/0001493152-24-036057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224036057/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:18:42.704493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}